BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 33283880)

  • 1. Signal transducer and activator of transcription 3 mediates apoptosis inhibition through reducing mitochondrial ROS and activating Bcl-2 in gemcitabine-resistant lung cancer A549 cells.
    Liu JS; Yeh CA; Huang IC; Huang GY; Chiu CH; Mahalakshmi B; Wen SY; Huang CY; Kuo WW
    J Cell Physiol; 2021 May; 236(5):3896-3905. PubMed ID: 33283880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinalizarin exerts an anti-tumour effect on lung cancer A549 cells by modulating the Akt, MAPK, STAT3 and p53 signalling pathways.
    Meng LQ; Liu C; Luo YH; Piao XJ; Wang Y; Zhang Y; Wang JR; Wang H; Xu WT; Liu Y; Wu YQ; Sun HN; Han YH; Jin MH; Shen GN; Zang YQ; Li J; Fang NZ; Cui YD; Jin CH
    Mol Med Rep; 2018 Feb; 17(2):2626-2634. PubMed ID: 29207064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raddeanin A induced apoptosis of non-small cell lung cancer cells by promoting ROS-mediated STAT3 inactivation.
    Li L; Chen M; Li G; Cai R
    Tissue Cell; 2021 Aug; 71():101577. PubMed ID: 34146943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of the drug resistance of a 2', 2-difluorodeoxycytide (gemcitabine)-resistant variant of the human lung adenocarcinoma cell line].
    Dong M; Feng FY; Lin C; Zhang XY; Fu M; Liang X; Zha YY; Lu HY; Wu M
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):323-8. PubMed ID: 15059518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rg3 inhibits gemcitabine-induced lung cancer cell invasiveness through ROS-dependent, NF-κB- and HIF-1α-mediated downregulation of PTX3.
    Ahmmed B; Kampo S; Khan M; Faqeer A; Kumar SP; Yulin L; Liu JW; Yan Q
    J Cell Physiol; 2019 Jul; 234(7):10680-10697. PubMed ID: 30628067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial uncoupling protein 2 regulates the effects of paclitaxel on Stat3 activation and cellular survival in lung cancer cells.
    Su WP; Lo YC; Yan JJ; Liao IC; Tsai PJ; Wang HC; Yeh HH; Lin CC; Chen HH; Lai WW; Su WC
    Carcinogenesis; 2012 Nov; 33(11):2065-75. PubMed ID: 22847181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent proapoptotic actions of dihydroartemisinin in gemcitabine-resistant A549 cells.
    Zhao C; Qin G; Gao W; Chen J; Liu H; Xi G; Li T; Wu S; Chen T
    Cell Signal; 2014 Oct; 26(10):2223-33. PubMed ID: 25018064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression.
    Wong FY; Liem N; Xie C; Yan FL; Wong WC; Wang L; Yong WP
    PLoS One; 2012; 7(12):e50786. PubMed ID: 23226540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTOR modulates resistance to gemcitabine in lung cancer in an MTORC2 dependent mechanism.
    Chawsheen MA; Dash PR
    Cell Signal; 2021 May; 81():109934. PubMed ID: 33545231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C-terminal region of Bfl-1 sensitizes non-small cell lung cancer to gemcitabine-induced apoptosis by suppressing NF-κB activity and down-regulating Bfl-1.
    Kim MK; Jeon YK; Woo JK; Choi Y; Choi DH; Kim YH; Kim CW
    Mol Cancer; 2011 Aug; 10():98. PubMed ID: 21843371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Silencing PBX1 expression induces apoptosis and ROS production of lung cancer cells].
    Yao XP; Peng HX; Wu JR
    Zhonghua Zhong Liu Za Zhi; 2020 Oct; 42(10):843-848. PubMed ID: 33113625
    [No Abstract]   [Full Text] [Related]  

  • 12. Cucurbitacin B enhances apoptosis in gefitinib resistant non‑small cell lung cancer by modulating the miR‑17‑5p/STAT3 axis.
    Yu B; Zheng L; Tang H; Wang W; Lin Y
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kahweol blocks STAT3 phosphorylation and induces apoptosis in human lung adenocarcinoma A549 cells.
    Kim HG; Hwang YP; Jeong HG
    Toxicol Lett; 2009 May; 187(1):28-34. PubMed ID: 19429240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3.
    Qi MM; Ge F; Chen XJ; Tang C; Ma J
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5242-5250. PubMed ID: 31298375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of JAK2/STAT3 signalling induces colorectal cancer cell apoptosis via mitochondrial pathway.
    Du W; Hong J; Wang YC; Zhang YJ; Wang P; Su WY; Lin YW; Lu R; Zou WP; Xiong H; Fang JY
    J Cell Mol Med; 2012 Aug; 16(8):1878-88. PubMed ID: 22050790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 10-HDA Induces ROS-Mediated Apoptosis in A549 Human Lung Cancer Cells by Regulating the MAPK, STAT3, NF-
    Lin XM; Liu SB; Luo YH; Xu WT; Zhang Y; Zhang T; Xue H; Zuo WB; Li YN; Lu BX; Jin CH
    Biomed Res Int; 2020; 2020():3042636. PubMed ID: 33376719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.
    Yeh CT; Huang WC; Rao YK; Ye M; Lee WH; Wang LS; Tzeng DT; Wu CH; Shieh YS; Huang CY; Chen YJ; Hsiao M; Wu AT; Yang Z; Tzeng YM
    Carcinogenesis; 2013 Dec; 34(12):2918-28. PubMed ID: 23880305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artemisia argyi extract induces apoptosis in human gemcitabine-resistant lung cancer cells via the PI3K/MAPK signaling pathway.
    Su SH; Sundhar N; Kuo WW; Lai SC; Kuo CH; Ho TJ; Lin PY; Lin SZ; Shih CY; Lin YJ; Huang CY
    J Ethnopharmacol; 2022 Dec; 299():115658. PubMed ID: 36075273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calotropin from Asclepias curasavica induces cell cycle arrest and apoptosis in cisplatin-resistant lung cancer cells.
    Mo EP; Zhang RR; Xu J; Zhang H; Wang XX; Tan QT; Liu FL; Jiang RW; Cai SH
    Biochem Biophys Res Commun; 2016 Sep; 478(2):710-5. PubMed ID: 27498029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of gemcitabine-resistant human non-small cell lung cancer A549 cells.
    Ikeda R; Vermeulen LC; Lau E; Jiang Z; Sachidanandam K; Yamada K; Kolesar JM
    Int J Oncol; 2011 Feb; 38(2):513-9. PubMed ID: 21152861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.